| AKI | Acute Kidney Injury |
| BCL-xL | B-cell lymphoma-extra large |
| CCA | Cell cycle arrest |
| Ccl2 | Chemokine (C-C motif) ligand 2 |
| CCN2 | Cellular communication network factor 2 |
| Cdkn1a | Cyclin-dependent kinase inhibitor 1A (p21) |
| Cdkn2a | Cyclin-dependent kinase inhibitor 2A (p16) |
| CKD | Chronic Kidney Disease |
| Col1a2 | Collagen type I alpha 2 chain |
| DDR | DNA Damage Response |
| ECM | Extracellular Matrix |
| FA | Folic acid |
| FAN | Folic-acid nephropathy |
| Fn1 | Fibronectin 1 |
| Havcr1 | Hepatitis A Virus Cellular Receptor 1 |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| IL1-β | Interleukin 1 β |
| Il6 | Interleukin 6 |
| IRI | Ischemia-Reperfusion Injury |
| Ki-67 | Marker of proliferation Ki-67 |
| KIM-1 | Kidney Injury Molecule-1 |
| Lcn2 | Lipocalin 2 |
| NF-KB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NGAL | Neutrophil Gelatinase-Associated Lipocalin |
| NLRP3 | NOD-like receptor protein 3 |
| SASP | Senescence-Associated Secretory Phenotype |
| Serpine1 | Serpin Family E Member 1 (also known as PAI-1) |
| TECs | Tubular Epithelial Cells |
| γH2AX | Phosphorylated Histone H2AX (marker of DNA damage) |